Oral Angiotensin Converting Enzyme Inhibitors for the Treatment of Delayed Inflammatory Reaction of Dermal Hyaluronic Acid Fillers Following COVID-19 Vaccination – A Model for Inhibition of Angiotensin II-Induced Cutaneous Inflammation
| Autor: | Girish Gilly Munavalli, Mary P. Lupo, Siri Knutsen-Larson, Roy G. Geronemus |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
delayed inflammatory reaction
delayed inflammatory reaction (DIR) Dermatology angiotensin II Pharmacology Article chemistry.chemical_compound Edema Renin–angiotensin system Hyaluronic acid lcsh:Dermatology medicine biology business.industry Lisinopril COVID-19 Angiotensin-converting enzyme lcsh:RL1-803 Angiotensin II Vaccination angiotensin-converting enzyme inhibitor chemistry Enzyme inhibitor biology.protein medicine.symptom business dermal filler medicine.drug |
| Zdroj: | JAAD Case Reports JAAD Case Reports, Vol 10, Iss, Pp 63-68 (2021) |
| ISSN: | 2352-5126 |
| Popis: | We present 4 cases of delayed inflammatory reaction (DIR) to facial dermal hyaluronic acid filler rapidly following vaccination for COVID-19. All DIRs occurred after a hyaluronic acid filler had been placed more than 1 year before vaccination. All patients responded rapidly to therapy with a low dose of oral lisinopril, an angiotensin-converting enzyme inhibitor (ACE-I), which decreases the cutaneous filler-related inflammatory reaction and edema by a novel proposed mechanism. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|